Barings LLC Vertex Pharmaceuticals Inc Transaction History

Barings LLC

$4.06 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$283.23 - $323.1 $209,306 - $238,770	739 New	739 $232,000
Q2 2022 Aug 08, 2022	BUY	$234.96 - $292.55 $404,836 - $504,063	1,723 New	1,723 $486,000
Q1 2022 May 13, 2022	SELL	$221.42 - $260.97 $251,311 - $296,200	-1,135 Closed	0 $0
Q4 2021 Feb 09, 2022	BUY	$177.01 - $223.45 $200,906 - $253,615	1,135 New	1,135 $249,000
Q3 2021 Nov 12, 2021	SELL	$181.39 - $202.99 $1.03 Million - $1.15 Million	-5,671 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$187.49 - $221.1 $23,623 - $27,858	-126 Reduced 2.17%	5,671 $1.14 Million
Q1 2021 May 11, 2021	SELL	$207.02 - $241.31 $99,783 - $116,311	-482 Reduced 7.68%	5,797 $1.25 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $3.22 Million - $4.3 Million	-15,561 Reduced 71.25%	6,279 $1.48 Million
Q3 2020 Nov 12, 2020	BUY	$255.65 - $303.1 $2 Million - $2.37 Million	7,804 Added 55.6%	21,840 $5.94 Million
Q1 2020 May 15, 2020	SELL	$199.77 - $247.81 $82,305 - $102,097	-412 Reduced 2.85%	14,036 $3.34 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $1.2 Million - $1.61 Million	-7,171 Reduced 33.17%	14,448 $3.16 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $125,004 - $140,691	-752 Reduced 3.36%	21,619 $3.66 Million
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $1.13 Million - $1.3 Million	6,842 Added 44.06%	22,371 $4.1 Million
Q1 2019 May 08, 2019	BUY	$163.73 - $194.7 $1.3 Million - $1.55 Million	7,952 Added 104.95%	15,529 $2.86 Million
Q4 2018 Feb 07, 2019	BUY	$151.91 - $192.21 $260,525 - $329,640	1,715 Added 29.26%	7,577 $1.26 Million
Q2 2018 Aug 03, 2018	BUY	$145.72 - $169.96 $466,595 - $544,211	3,202 Added 120.38%	5,862 $996,000
Q4 2017 Feb 08, 2018	BUY	$137.28 - $155.55 $365,164 - $413,763	2,660	2,660 $399,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.61 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.33 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.06 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account